https://www.pharmanow.live/latest-news/pharming-group-fda-approval-leniolisib-children-apds 2026-09-11T23:18:25+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 Pharming Group Gains FDA Approval for Leniolisib in Children Aged 4–11 with APDS FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b91f9aa2-bd38-4dcf-9820-dc161878f47f/4d47a470-5afa-4749-aa25-0a836098ae0e.png https://www.pharmanow.live/latest-news/lonza-commercial-spray-drying-facility-oregon-sdd-manufacturing 2026-09-11T13:51:30+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 Lonza Builds Oregon Spray-Drying Facility To Expand SDD Capacity Lonza https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b2eccf0e-ce5f-4e49-8a3b-82df5afa3f1e/bc6bbde4-0588-43e3-905b-add9fe7eb8b0.png https://www.pharmanow.live/latest-news/nicox-nmpa-acceptance-ncx-470-nda-china-review 2026-09-11T13:47:12+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 China NMPA Accepts Nicox NCX 470 NDA; Decision In 18 Months China NMPA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/b2eccf0e-ce5f-4e49-8a3b-82df5afa3f1e/01044b9a-35e6-4a3e-a60d-447e1513c34c.png https://www.pharmanow.live/latest-news/axcelead-hitaka-glp-1-rodent-nausea-model-jsso-jsto-2026 2026-09-11T10:37:33+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 Hitaka To Present Axcelead GLP-1 Rodent Nausea Data At Obesity 26 Hitaka https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://axcelead-us.com/wp-content/uploads/2025/04/hitaka.jpg https://www.pharmanow.live/latest-news/xortx-initiates-gmp-manufacturing-xorlo-clinical-nda-dossier 2026-09-11T13:44:14+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 XORTX Initiates GMP Manufacturing Of XORLO™ For Dual Dossier XORTX https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/xortx-initiates-gmp-manufacturing-xorlo-clinical20260911134359.webp https://www.pharmanow.live/latest-news/fda-nih-cdc-workshop-valley-fever-vaccine-regulatory-pathway-2024 2026-09-11T13:39:43+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 FDA, NIH & CDC Host Workshop On Valley Fever Vaccine Pathway FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-nih-cdc-workshop-valley-fever-vaccine-pathway20260911133930.webp https://www.pharmanow.live/latest-news/medical-action-industries-class-i-correction-epidural-kits-huons-sterility-cascade 2026-09-11T10:37:39+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 Medical Action Recalls Epidural Kits Over Sterility Risk Medical Action https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/a72bc3d0-b709-497c-98a4-e494e7607feb/53139a57-2b33-4fb4-8ce6-45e5bb581c50.png https://www.pharmanow.live/latest-news/roche-fda-approval-cobas-malaria-nat-donor-screening 2026-09-11T13:25:42+05:30 Pharma Now en 2026-09-11T00:00:00+05:30 Roche Cobas Malaria Test Gets FDA Approval For Donor Screening Roche https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/roche-fda-approval-cobas-malaria-nat-screening20260911132537.webp https://www.pharmanow.live/latest-news/cosette-pharmaceuticals-appoints-andrew-adams-vp-supply-chain-sourcing 2026-09-11T10:49:50+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Cosette Pharmaceuticals Appoints Andrew Adams as Vice President of Supply Chain and Sourcing Cosette https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cosette-pharmaceuticals-appoints-andrew-adams-vp20260911104939.webp https://www.pharmanow.live/latest-news/abbvie-atogepant-phase-3-luna-menstrual-migraine-results 2026-09-11T10:43:09+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 AbbVie Achieves Phase 3 Primary and All Secondary Endpoints for Atogepant in Menstrual Migraine AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie-atogepant-phase-3-luna-menstrual-migraine20260911104252.webp https://www.pharmanow.live/latest-news/fda-removes-paba-trolamine-salicylate-otc-sunscreen-monograph-2026 2026-09-11T10:40:30+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 FDA Removes PABA and Trolamine Salicylate from OTC Sunscreen Monograph in September 2026 Final Order https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-removes-paba-trolamine-sunscreen-monograph20260911103919.webp https://www.pharmanow.live/latest-news/roche-fda-priority-review-enspryng-sbla-mogad-january-2027 2026-09-11T10:36:28+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Roche Gains FDA Priority Review for Enspryng sBLA in MOGAD with Decision Due January 2027 Roche https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/roche-fda-priority-review-enspryng-mogad20260911103615.webp https://www.pharmanow.live/latest-news/medicus-pharma-skinject-phase-2-csr-200mcg-dose-basal-cell-carcinoma 2026-09-11T10:31:18+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Medicus Pharma Identifies 200 µg D-MNA Dose as Lead in Phase 2 SkinJect CSR for Basal Cell Carcinoma Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/medicus-pharma-skinject-phase-2-basal-cell-carcinoma20260911103108.webp https://www.pharmanow.live/latest-news/sarborg-quantum-computing-signature-intelligence-neuropsychiatric-drug-discovery 2026-09-11T10:22:47+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Sarborg Applies Quantum Computing and Signature Intelligence Models to Neuropsychiatric Drug Discovery Sarborg https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sarborg-quantum-computing-neuropsychiatric-drug-discovery20260911102237.webp https://www.pharmanow.live/latest-news/ritedose-appoints-carolyn-berg-vice-president-strategic-growth 2026-09-10T22:31:42+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Ritedose Appoints Carolyn Berg as Vice President of Strategic Growth in Sterile BFS Expansion Ritedose https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/Resource/Download/1d5f4368-063b-4fb9-9364-e6cf4fe049c8 https://www.pharmanow.live/latest-news/fda-ich-m3r2-nonclinical-safety-studies-clinical-trial-authorization 2026-09-10T13:06:34+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 FDA Resurfaces ICH M3(R2) Guidance on Nonclinical Safety Studies FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-ich-m3r2-nonclinical-safety-studies20260910130628.webp https://www.pharmanow.live/latest-news/novo-nordisk-fda-approval-rebinyn-recombinant-glycopegylated-factor-ix-hemophilia-b 2026-09-10T13:11:14+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 Novo Nordisk Rebinyn Obtains Fda Approvals For Hemophilia B Cases Novo Nordisk https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-fda-approval-rebinyn-hemophilia-b20260910131100.webp https://www.pharmanow.live/latest-news/fda-otat-gene-therapy-cmc-town-hall-series-advanced-therapy-manufacturers 2026-09-10T10:29:37+05:30 Pharma Now en 2026-09-10T00:00:00+05:30 FDA OTAT Launches Gene Therapy CMC Town Hall Series FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/471f2524-97bb-4616-9ac3-71e7ca1f298d/7ada22f5-ddf1-4307-9543-08d93876e8a8.png